Determination of physostigmine in plasma by high-performance liquid chromatography and fluorescence detection
- 1 February 1989
- journal article
- research article
- Published by Elsevier in Analytical Biochemistry
- Vol. 177 (1) , 207-211
- https://doi.org/10.1016/0003-2697(89)90042-0
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Toxicity of Anticholinesterases: Interactions of Pyridostigmine and Physostigmine with SomanDrug and Chemical Toxicology, 1984
- A theoretical kinetic analysis of the protective action exerted by eserine and other carbamate anticholinesterases against poisoning by organophosphorus compoundsBiochemical Pharmacology, 1983
- Apomorphine and Other Dopaminomimetics: Basic Pharmacology, Vol. IAmerican Journal of Psychiatry, 1982
- Quantitative determination of the cholinesterase inhibitor physostigmine in brain tissue samples using reversed-phase high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- The inhibition and protection of cholinesterase by physostigmine and pyridostigmine against soman poisoning in vivoFundamental and Applied Toxicology, 1981
- The protection of animals against organophosphate poisoning by pretreatment with a carbamateToxicology and Applied Pharmacology, 1978
- Quantitative Assay of Physostigmine in Human Whole BloodJournal of Pharmaceutical Sciences, 1977
- Antagonism of Neuromuscular BlockadeAnesthesiology, 1976
- The determination of physostigmine by thin-layer chromatography and ultraviolet spectrophotometryJournal of Chromatography A, 1973
- Treatment of Myasthenia GravisNew England Journal of Medicine, 1973